References
- Ben‐David B., DeMeo P. J., Lucyk C., Solosko D. A. Comparison of minidose lidocaine‐fentanyl spinal anesthesia and local anesthesia/propofol infusion for outpatient knee arthroscopy. Anesth. Analg. 2001; 93: 319–325
- Strichartz G. R., Richie J. M. The action of local anesthetics on I: ion channels of excitable tissues. Local Anesthetics Handbook of Experimental Pharmacology, G. R. Strichartz. Springer Verlag, Berlin 1987; Vol. 81: 21–53
- Morganti P., Ruocco E., Wolf R., Ruocco V. Percutaneous absorption and delivery systems (3). Clin. Dermatol. 2001; 19: 489–501, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hou S. M., Yu H. Y. Comparison of absorption of aqueous lidocaine and liposome lidocaine following topical application on rabbit vessels. J. Orthop. Res. 1994; 12: 294–298, [PUBMED], [INFOTRIEVE]
- Hou S. M., Yu H. Y. Comparison of systemic absorption of aqueous lidocaine and liposome lidocaine following intra‐articular injection in rabbits. J. Formos. Med. Assoc. 1997; 96: 141–143, [PUBMED], [INFOTRIEVE], [CSA]
- Evrard D., Touitou E., Kolusheva S., Fishov Y., Jelinek R. A new colorimetric assay for studying and rapid screening of membrane penetration enhancers. Pharm. Res. 2001; 18: 943–949, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Angust B. J., Rogers N. Y. Comparison of the effects of various transmucosal absorption promoters on buccal insulin delivery. Int. J. Pharm. 1989; 53: 227–235, [CROSSREF]
- Shin S. C., Lee H. J. Enhanced transdermal delivery of triprolidine from the ethylene‐vinyl acetate matrix. Eur. J. Pharm. Biopharm. 2002; 54: 325–328, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Shin S. C., Cho C. W., Oh I. J. Effects of non‐ionic surfactants as permeation enhancers towards piroxicam from the poloxamer gel through rat skins. Int. J. Pharm. 2001; 222: 199–203, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Shin S. C., Kim J., Yoon M. K., Oh I. J., Choi J. S. Transdermal delivery of triprolidine using TPX polymer membrane. Int. J. Pharm. 2002; 235: 141–147, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Shin S. C., Cho C. W., Oh I. J. Enhanced efficacy by percutaneous absorption of piroxicam from the poloxamer gel in rats. Int. J. Pharm. 2002; 193: 213–218, [CROSSREF]
- Shin S. C., Shin E. Y., Cho C. W. Enhancing effects of fatty acids on piroxicam permeation through rat skins. Drug Dev. Ind. Pharm. 2000; 26: 563–566, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Shin S. C., Cho C. W., Choi H. K. Permeation of piroxicam from the poloxamer gels. Drug Dev. Ind. Pharm. 1999; 25: 273–279, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ishida M., Machida Y., Nambu N., Nagai T. New mucosal dosage form of insulin. Chem. Pharm. Bull. 1981; 209: 810–816
- Shokri J., Nokhodchi A., Dashbolaghi A., Hassan‐Zadeh D., Ghafourian T., Barzegar J. M. The effect of surfactants on the skin penetration of diazepam. Int. J. Pharm. 2001; 228: 99–107, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Miyazaki S., Ishii K., Takada M. Controlled release of anticancer agents through ethylene‐vinyl acetate copolymer membranes. Yakuzaigaku 1983; 42: 259